Human Albumin Csl Behring

Human Albumin Csl Behring is a sterile intravenous solution containing human albumin, a plasma protein, supplied in a standard concentration (e.g., 20% w/v) for clinical use. It is manufactured in the European Union and prescribed by healthcare professionals as a volume expander to restore and maintain circulatory volume in patients with hypoalbuminemia or acute blood loss. The product is administered under medical supervision and stored according to label instructions.

Human Albumin Csl Behring is employed clinically as a volume expander and protein replacement in several medical situations where plasma albumin levels are low or rapid fluid shifts occur.

- Management of hypovolemia due to acute blood loss or trauma. - Treatment of hypoalbuminemia associated with liver cirrhosis or nephrotic syndrome. - Support during major surgery or extensive burns to maintain oncotic pressure. - Adjunct therapy in patients receiving parenteral nutrition with low serum albumin. - Correction of dilutional coagulopathy in massive transfusion protocols.

Adverse reactions to Human Albumin Csl Behring are generally infrequent but may range from mild to severe.

Common: - Transient fever or chills. - Mild hypotension or hypertension. - Headache or dizziness.

Serious: - Anaphylactic or severe allergic reaction. - Pulmonary edema from volume overload. - Acute respiratory distress syndrome (ARDS).

When prescribing Human Albumin Csl Behring, clinicians should evaluate patient-specific factors and monitor for potential complications.

- Assess volume status to avoid fluid overload. - Use caution in patients with heart failure or renal insufficiency. - Monitor serum albumin and electrolytes during therapy. - Adjust dose in patients with severe hypoalbuminemia. - Avoid rapid infusion rates; infuse over recommended time. - Discontinue if signs of allergic reaction appear.

Human Albumin may interact with other agents that affect fluid balance, coagulation, or immune response.

Avoid: - Concomitant use of high‑dose diuretics that may exacerbate hypovolemia. - Simultaneous administration of other volume expanders without careful monitoring. - Use with agents that increase risk of pulmonary edema (e.g., excessive crystalloid fluids).

Use with caution: - Blood products or plasma derivatives that may increase oncotic load. - Medications that bind albumin (e.g., warfarin, phenytoin) as they may alter drug levels. - Immunosuppressive therapies that could mask allergic reactions.